台股 » 華上 » 個股財報 » 每月營收

華上

(6289)
  • 股價
    1.35
  • 漲跌
    ▼0.15
  • 漲幅
    -10.00%
  • 成交量
    1,203
  • 產業
    上市 發光二極體(LED) ▼0.34%
  • 本地時間:13:35(已收盤)

    27人加入追蹤

    立即追蹤

華上 (6289) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

華上 (6289) 月營收分析比較圖

華上 (6289) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2022/082,0214,858-10.1%-58.4%23,27445,695-49.1%
2022/072,2474,003-26.2%-43.9%21,25340,837-48%
2022/063,0464,90979.4%-38%19,00636,834-48.4%
2022/051,6985,401-28.5%-68.6%15,96131,924-50%
2022/042,3765,354-53.4%-55.6%14,26326,524-46.2%
2022/035,1037,11926.2%-28.3%11,88721,170-43.8%
2022/024,0445,32247.6%-24%6,78414,051-51.7%
2022/012,7408,728-63.4%-68.6%2,7408,728-68.6%
2021/127,49110,111119.1%-25.9%62,18677,932-20.2%
2021/113,4198,24349.6%-58.5%54,69567,821-19.4%
2021/102,2857,865-30.7%-70.9%51,27659,578-13.9%
2021/093,2966,647-32.2%-50.4%48,99051,714-5.3%
2021/084,8584,45821.4%9%45,69545,0671.4%
2021/074,0036,413-18.5%-37.6%40,83740,6090.6%
2021/064,9095,802-9.1%-15.4%36,83434,1967.7%
2021/055,4015,8770.9%-8.1%31,92428,39412.4%
2021/045,3545,340-24.8%0.3%26,52422,51717.8%
2021/037,1196,79433.8%4.8%21,17017,17723.2%
2021/025,3225,908-39%-9.9%14,05110,38335.3%
2021/018,7284,475-13.7%95%8,7284,47595%
2020/1210,1115,62022.7%79.9%77,932114,295-31.8%
2020/118,2437,2794.8%13.2%67,821108,675-37.6%
2020/107,86511,89518.3%-33.9%59,578101,396-41.2%
2020/096,64711,30549.1%-41.2%51,71489,501-42.2%
2020/084,45810,652-30.5%-58.1%45,06778,196-42.4%
2020/076,4139,80810.5%-34.6%40,60967,544-39.9%
2020/065,8028,857-1.3%-34.5%34,19657,737-40.8%
2020/055,8778,57010.1%-31.4%28,39448,880-41.9%
2020/045,34010,034-21.4%-46.8%22,51740,309-44.1%
2020/036,79410,01615%-32.2%17,17730,275-43.3%
2020/025,90810,22732%-42.2%10,38320,259-48.7%
2020/014,47510,032-20.4%-55.4%4,47510,032-55.4%
2019/125,62011,136-22.8%-49.5%114,295184,560-38.1%
2019/117,27912,050-38.8%-39.6%108,675173,424-37.3%
2019/1011,89511,0245.2%7.9%101,396161,374-37.2%
2019/0911,3059,7466.1%16%89,501150,350-40.5%
乳癌新藥剋必達上市 華上生醫IPO時程加速Anue鉅亨-2023/09/12
〈華上生醫展望〉乳癌新成分新藥拓展新適應症 肝癌試驗拚年底完成Anue鉅亨-2023/09/08
華上 相關文章